Schedule 13D ownership disclosure
OHR PHARMACEUTICAL INC
Security class unavailable · CUSIP: 67778H200
Event date: 2016-07-18
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 3.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001387131-16-006273
- Form type
- SC 13D
- Filer
- NeuBase Therapeutics, Inc.
- CIK
- CIK 1173281
- Filed
- Aug 02, 2016
- Reporting period
- Jul 18, 2016
- Description
- Schedule 13D beneficial ownership